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more than the deaths observed from HIV/AIDS, malaria and
tuberculosis combined.1 This is particularly true in sub-
Saharan Africa (SSA), anecdotally demonstrated by close to
half of the beds in one East African public hospital occupied
by trauma victims.2,3 In addition, the epidemic of trauma
affects mainly young, economically active people.2 This
increasing bulk of trauma stresses an already overburdened
health system in a number of ways, one of which is increasing
the demand on blood products and resuscitation ﬂuids.
The World Health Organization in its manual Guidelines to
Clinical Use of Blood emphasizes the judicious use of transfu-
sion alternatives in trauma resuscitation, which several SSA
states have adopted in their respective National Clinical
Guidelines on blood use.4 However, the majority of these do
not address the key questions of when to introduce which
resuscitation ﬂuid (blood, crystalloids or colloids) and how
much in a reliable, evidence based fashion. This in turns leaves
the low to middle income setting emergency centre clinician
with no genuine direction when caring for the major trauma
patient.5
In treating major trauma, emergency staff are challenged by
the pathophysiological outcomes of management of
haemorrhagic shock with colloids and/ or crystalloids. Once
haemorrhagic shock has been controlled, further outcome is
determined by the rate and accuracy of ﬂuid use, the cellular
response of individual organ systems, and the balance of
inﬂammatory mediators over subsequent hours and days. To
put it plainly, the patient may survive acutely but die days or
weeks later of multiple organ damage as a result of incorrect
ﬂuid therapy. Rapid administration of relatively inexpensive
crystalloids (often considered preferred ﬁrst line blood transfu-
sion alternatives in low to middle income settings) can lead toexcessive haemorrhage or re-bleed from previously haemo-
static areas.6,7 This ends up leading to a reversal of the com-
pensatory physiological clotting mechanisms and regrettably
a not so surprising poor outcome further down the line.8
These challenges can only be mitigated in trauma settings that
allow close monitoring of the major trauma patient and with
consideration for other types of resuscitation ﬂuid, such as
blood products, used during the resuscitation phase.
Unfortunately, these are not easy to come by in the vast
majority of SSA emergency centres and hospitals, despite
recent evidence showing the early use of blood products
reduced mortality in major trauma.9
The challenges faced by SSA National transfusion services
essentially translate into blood product shortages when dealing
with the trauma patient both in emergency trauma and elective
surgical situations. In essence these include inefﬁcient supply
chain, inequitable access and increased demand, suboptimal
or unjustiﬁed use, risk of transfusion transmitted infections,
and weak quality control systems (especially documentation,
availability and utilization of standard operating procedures
at the bedside, training, benchmarked monitoring and evalua-
tion, and in-hospital haemovigilance).9 It is thus not a major
revelation that the above scenarios mainly occur in settings
where there are no patient blood management programs that
can perform the following vital tasks:
1. Provide opportunities to National transfusion services to
extend their inﬂuence into the hospital setting to improve
safety and effective use of blood products in emergency
situations,
2. Facilitate collection and analysis of data on blood usage in
emergency or elective surgical situations and thereby pro-
vide non-punitive, constructive feedback to the trauma
and emergency care teams,
3. Provide opportunities to national transfusion services to
liaise with hospitals on a number of blood managerial
and operational fronts, such as development of strong
human resources who are equipped with appropriate
knowledge and skills in transfusion medicine, and
4. Ensure a sustainable, constant and uniform distribution of
transfusion alternatives, given the meagre health ﬁnancing
in most SSA National budgets.10
100 EditorialOne solution is to strengthen surveillance procedures in the
hospital setting to collect, assess and evaluate information on
expected and unexpected outcomes of the chosen resuscitation
alternatives (ﬂuid for blood, or blood for blood). This will con-
stitute establishment and implementation of the in-hospital
arms of pharmacovigilance. The results of this evaluation
can then be communicated in a timely manner to the clinicians
that manage acute trauma, thus completing the audit cycle and
offering improvement. It is also important to note that
although the care provided by a trauma surgeon is often use-
ful, it is also sometimes useless and occasionally harmful. To
make an appropriate choice of which intervention will produce
the desired outcome, robust local evidence is needed. This can
only be achieved through carefully designed studies, preferably
randomized controlled trials, conducted within the African set-
ting (which in turn should impart ownership along with better
adherence to practice changes). Involvement of all stakehold-
ers in the planning of procurement, processing and distribution
of resuscitation supplies (blood products and ﬂuids) is equally
important. This can be achieved by development of balanced
and ethical consensus on regulation, safety and adequacy of
supplies reached by increased dialogue interaction between
pharmaceutical and blood regulatory authorities, Ministries
of Health, clinicians and representatives of patient bodies. It
is important to note that although generic guidance can be
offered, a one size ﬁts all solution is unlikely to be useful for
every SSA emergency centre due to the huge variability within
the different settings. Aspiring to reach the optimal transfusion
situation, with goals set along the way to allow a timely trans-
formation, is perhaps a more achievable starting point, as this
approach could be customized for each setting.
When attempting to select an appropriate resuscitation
strategy to treat haemorrhagic shock, trauma surgeons, emer-
gency physicians and emergency centre clinicians are currently
standing at a challenging African cross-road. This is essentially
due to a combination of a short supply and cost of blood prod-
ucts, as well as the lack of local evidence to base resuscitation
decisions. Broadly and realistically, these can be mitigated by
jointly developing managerial and operational strategies to
manage haemorrhagic shock within the conﬁnes of the existing
limited resources.Conﬂict of interest
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